tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BEAM Stock Latest News

JPMorgan biotech/Euro pharma analysts hold analyst/industry conference call
The FlyJPMorgan biotech/Euro pharma analysts hold analyst/industry conference call
10d ago
WVE
BEAM
Cathie Wood’s ARK Investment buys 135K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 135K shares of Beam Therapeutics today
25d ago
BEAM
Beam Therapeutics’ BEAM-302: Promising Clinical Data and Market Potential Drive Buy Rating
PremiumRatings
Beam Therapeutics’ BEAM-302: Promising Clinical Data and Market Potential Drive Buy Rating
29d ago
BEAM
Beam Therapeutics presents additional data for BEAM-302 in AATD
PremiumThe Fly
Beam Therapeutics presents additional data for BEAM-302 in AATD
30d ago
BEAM
Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today
1M ago
BEAM
Biotech stocks slide as Marks resignation seen being negative for sector
PremiumThe FlyBiotech stocks slide as Marks resignation seen being negative for sector
1M ago
DYN
MGX
BMO says Peter Marks resignation ‘significant negative’ for biotech
Premium
The Fly
BMO says Peter Marks resignation ‘significant negative’ for biotech
1M ago
MGX
BEAM
Beam Therapeutics upgraded to Buy at BofA after BEAM-302 data
Premium
The Fly
Beam Therapeutics upgraded to Buy at BofA after BEAM-302 data
1M ago
BEAM
Beam Therapeutics upgraded to Buy from Neutral at BofA
PremiumThe Fly
Beam Therapeutics upgraded to Buy from Neutral at BofA
1M ago
BEAM
Beam announces FDA clearance of BEAM-302 investigational new drug application
PremiumThe Fly
Beam announces FDA clearance of BEAM-302 investigational new drug application
1M ago
BEAM
Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today
1M ago
BEAM
Promising Data and Future Potential Drive Buy Rating for Beam Therapeutics
PremiumRatings
Promising Data and Future Potential Drive Buy Rating for Beam Therapeutics
1M ago
BEAM
Cathie Wood Buys the Dip in Baidu Stock (BIDU) and Sells Roblox
PremiumMarket NewsCathie Wood Buys the Dip in Baidu Stock (BIDU) and Sells Roblox
1M ago
ARKQ
ARKW
Strategic Advantage and Exclusive Rights Bolster Beam Therapeutics’ Buy Rating
Premium
Ratings
Strategic Advantage and Exclusive Rights Bolster Beam Therapeutics’ Buy Rating
1M ago
BEAM
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
Premium
Weekend Updates
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
2M ago
U
BEAM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PFE
ALGS
Beam Therapeutics price target raised to $64 from $56 at Citi
PremiumThe Fly
Beam Therapeutics price target raised to $64 from $56 at Citi
2M ago
BEAM
Promising BEAM-302 Trial Results and Strong Financial Position Support Buy Rating for Beam Therapeutics
PremiumRatings
Promising BEAM-302 Trial Results and Strong Financial Position Support Buy Rating for Beam Therapeutics
2M ago
BEAM
Beam Therapeutics: Promising Phase 1 Results for BEAM-302 in AATD, Hold Rating Due to Long-term Efficacy Uncertainty
PremiumRatings
Beam Therapeutics: Promising Phase 1 Results for BEAM-302 in AATD, Hold Rating Due to Long-term Efficacy Uncertainty
2M ago
BEAM
Beam Therapeutics upgraded yesterday at Scotiabank after positive AATD data
PremiumThe FlyBeam Therapeutics upgraded yesterday at Scotiabank after positive AATD data
2M ago
BEAM
Cathie Wood’s ARK Investment buys 485K shares of Beam Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 485K shares of Beam Therapeutics today
2M ago
BEAM
JonesResearch upgrades Beam Therapeutics to Buy on de-risking data
Premium
The Fly
JonesResearch upgrades Beam Therapeutics to Buy on de-risking data
2M ago
BEAM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >